X2723CBDilation of Inferior Vena Cava and Iliocaval Confluence with Open-structure Polymer Lattice Intraluminal Device, Percutaneous Approach, New Technology Group 11
- Billable / Specific Code
- New for FY 2027
X2723CB is a billable ICD-10-PCS procedure code for Dilation of Inferior Vena Cava and Iliocaval Confluence with Open-structure Polymer Lattice Intraluminal Device, Percutaneous Approach, New Technology Group 11. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to 33 MS-DRGs. The root operation Dilation involves expanding an orifice or the lumen of a tubular body part.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | 2 | Cardiovascular System |
| 3 | Operation | 7 | Dilation |
| 4 | BodyPart | 2 | Inferior Vena Cava and Iliocaval Confluence |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | C | Intraluminal Device, Open-structure Polymer Lattice |
| 7 | Qualifier | B | New Technology Group 11 |
In the ICD-10-PCS Alphabetic Index
These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:
Code History
- 06703DZ — Dilation of Inf Vena Cava with Intralum Dev, Perc Approach
Questions About X2723CB
Is X2723CB a billable code?
Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Dilation of Inferior Vena Cava and Iliocaval Confluence with Open-structure Polymer Lattice Intraluminal Device, Percutaneous Approach, New Technology Group 11 on inpatient claims from October 1, 2026 through September 30, 2027.
What do the characters in X2723CB mean?
The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character 2 is the Body System (Cardiovascular System); the 3rd character 7 is the Operation (Dilation); the 4th character 2 is the BodyPart (Inferior Vena Cava and Iliocaval Confluence); the 5th character 3 is the Approach (Percutaneous); the 6th character C is the Device/Substance/Technology (Intraluminal Device, Open-structure Polymer Lattice); the 7th character B is the Qualifier (New Technology Group 11).
What MS-DRG does X2723CB group to?
On an inpatient stay, Dilation of Inferior Vena Cava and Iliocaval Confluence with Open-structure Polymer Lattice Intraluminal Device, Percutaneous Approach, New Technology Group 11 maps to MS-DRGs 037, 038, 039, 166, 167, 168, 252, 253, 254, 356, 357, 358, 423, 424, 425, 515, 516, 517, 579, 580, 581, 628, 629, 630, 673, 674, 675, 907, 908, 909, 957, 958, 959, with relative weights from 1.1858 to 7.5502. The MS-DRG sets the fixed Medicare payment for the stay.